Biostar Pharmaceuticals, Inc. — key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2016)

$2.4M

Net Income/Loss (FY2016)

-$5.7M

Total Assets (FY2016)

$42.5M

Total Equity (FY2016)

$36.9M

Cash Flows from Operating Activities (FY2016)

$4.9M

Source: Biostar Pharmaceuticals, Inc. 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.